Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3
2021 6
2022 6
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.
de Vries M, Mohamed AS, Prescott RA, Valero-Jimenez AM, Desvignes L, O'Connor R, Steppan C, Devlin JC, Ivanova E, Herrera A, Schinlever A, Loose P, Ruggles K, Koralov SB, Anderson AS, Binder J, Dittmann M. de Vries M, et al. bioRxiv. 2021 Feb 19:2020.08.28.272880. doi: 10.1101/2020.08.28.272880. Preprint. bioRxiv. 2021. PMID: 32869028 Free PMC article. Updated.
Sex and Gender Disparities in Melanoma.
Bellenghi M, Puglisi R, Pontecorvi G, De Feo A, Carè A, Mattia G. Bellenghi M, et al. Cancers (Basel). 2020 Jul 7;12(7):1819. doi: 10.3390/cancers12071819. Cancers (Basel). 2020. PMID: 32645881 Free PMC article. Review.
A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.
de Vries M, Mohamed AS, Prescott RA, Valero-Jimenez AM, Desvignes L, O'Connor R, Steppan C, Devlin JC, Ivanova E, Herrera A, Schinlever A, Loose P, Ruggles K, Koralov SB, Anderson AS, Binder J, Dittmann M. de Vries M, et al. J Virol. 2021 Feb 23;95(10):e01819-20. doi: 10.1128/JVI.01819-20. Online ahead of print. J Virol. 2021. PMID: 33622961 Free PMC article.
15 results